Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer

FJH Drost, DF Osses, D Nieboer… - Cochrane Database …, 2019 - cochranelibrary.com
Background Multiparametric magnetic resonance imaging (MRI), with or without MRI‐
targeted biopsy, is an alternative test to systematic transrectal ultrasonography‐guided …

Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a Cochrane …

FJH Drost, D Osses, D Nieboer, CH Bangma… - European urology, 2020 - Elsevier
Context Magnetic resonance imaging (MRI), with or without MRI-targeted biopsy (MRI
pathway), is an alternative test to systematic transrectal ultrasonography-guided biopsy in …

Classification of cancer at prostate MRI: deep learning versus clinical PI-RADS assessment

P Schelb, S Kohl, JP Radtke, M Wiesenfarth… - Radiology, 2019 - pubs.rsna.org
Background Men suspected of having clinically significant prostate cancer (sPC)
increasingly undergo prostate MRI. The potential of deep learning to provide diagnostic …

[HTML][HTML] Prostate imaging-reporting and data system steering committee: PI-RADS v2 status update and future directions

AR Padhani, J Weinreb, AB Rosenkrantz, G Villeirs… - European urology, 2019 - Elsevier
Abstract Context The Prostate Imaging-Reporting and Data System (PI-RADS) v2 analysis
system for multiparametric magnetic resonance imaging (mpMRI) detection of prostate …

PI-RADS steering committee: the PI-RADS multiparametric MRI and MRI-directed biopsy pathway

AR Padhani, J Barentsz, G Villeirs, AB Rosenkrantz… - Radiology, 2019 - pubs.rsna.org
High-quality evidence shows that MRI in biopsy-naive men can reduce the number of men
who need prostate biopsy and can reduce the number of diagnoses of clinically insignificant …

Detection of clinically significant prostate cancer using magnetic resonance imaging–ultrasound fusion targeted biopsy: a systematic review

M Valerio, I Donaldson, M Emberton, B Ehdaie… - European urology, 2015 - Elsevier
Context The current standard for diagnosing prostate cancer in men at risk relies on a
transrectal ultrasound–guided biopsy test that is blind to the location of the cancer. To …

Multiparametric magnetic resonance imaging (MRI) and MRI–transrectal ultrasound fusion biopsy for index tumor detection: correlation with radical prostatectomy …

JP Radtke, C Schwab, MB Wolf, MT Freitag, CD Alt… - European urology, 2016 - Elsevier
Background Multiparametric magnetic resonance imaging (mpMRI) and MRI fusion targeted
biopsy (FTB) detect significant prostate cancer (sPCa) more accurately than conventional …

Resolving the immune landscape of human prostate at a single-cell level in health and cancer

ZK Tuong, KW Loudon, B Berry, N Richoz, J Jones… - Cell Reports, 2021 - cell.com
The prostate gland produces prostatic fluid, high in zinc and citrate and essential for the
maintenance of spermatozoa. Prostate cancer is a common condition with limited treatment …

Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?

JP Grummet, M Weerakoon, S Huang… - BJU …, 2014 - Wiley Online Library
Objective To determine the rate of hospital re‐admission for sepsis after transperineal (TP)
biopsy using both local data and worldwide literature, as there is growing interest in TP …

Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy‐naïve men with suspicion of prostate cancer

NL Hansen, T Barrett, C Kesch, L Pepdjonovic… - BJU …, 2018 - Wiley Online Library
Objectives To analyse the detection rates of primary magnetic resonance imaging (MRI)‐
fusion transperineal prostate biopsy using combined targeted and systematic core …